Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site.
about
Laminin receptor involvement in the anti-angiogenic activity of pigment epithelium-derived factorA Chronic Fatigue Syndrome - related proteome in human cerebrospinal fluid.Neuroprotection as a Therapeutic Target for Diabetic RetinopathyPEDF and its roles in physiological and pathological conditions: implication in diabetic and hypoxia-induced angiogenic diseasesAlzheimer's disease and non-demented high pathology control nonagenarians: comparing and contrasting the biochemistry of cognitively successful agingLeukostasis and pigment epithelium-derived factor in rat models of diabetic retinopathyPerivascular macrophage-like melanocyte responsiveness to acoustic trauma--a salient feature of strial barrier associated hearing loss.Perivascular-resident macrophage-like melanocytes in the inner ear are essential for the integrity of the intrastrial fluid-blood barrier.Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin.Novel method for expression and purification of human pigment epithelium-derived factor with biological activities in Escherichia coli.Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects.Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in macular edema with central retinal vein occlusion.Anti-angiogenic and anti-inflammatory effects of SERPINA3K on corneal injury.Antipermeability function of PEDF involves blockade of the MAP kinase/GSK/beta-catenin signaling pathway and uPAR expression.PEDF regulates vascular permeability by a γ-secretase-mediated pathway.Pigment epithelium-derived factor (PEDF) interacts with transportin SR2, and active nuclear import is facilitated by a novel nuclear localization motif.Pigment epithelium-derived factor is related to macular microcirculation in patients with macular edema and branch retinal vein occlusion.Visual prognosis and vitreous molecules after vitrectomy for macular edema with branch retinal vein occlusion.Pigment epithelium-derived factor inhibits retinal microvascular dysfunction induced by 12/15-lipoxygenase-derived eicosanoids.Association of PEDF polymorphisms with age-related macular degeneration and polypoidal choroidal vasculopathy: a systematic review and meta-analysis.Vitreous inflammatory factors and serous retinal detachment in central retinal vein occlusion: a case control series.Delayed Treatment with a Small Pigment Epithelium Derived Factor (PEDF) Peptide Prevents the Progression of Diabetic Renal InjuryThe role of growth factors in the pathogenesis of diabetic retinopathy.Potential therapeutic effects of pigment epithelium-derived factor for treatment of diabetic retinopathyStrategies for blocking angiogenesis in diabetic retinopathy: from basic science to clinical practice.Analysis of three pigment epithelium-derived factor gene polymorphisms in patients with exudative age-related macular degeneration.Protective role of small pigment epithelium-derived factor (PEDF) peptide in diabetic renal injury.Vasoinhibins: novel inhibitors of ocular angiogenesis.Anti-tumor effect of adenovirus-mediated gene transfer of pigment epithelium-derived factor on mouse B16-F10 melanomaSilver nanoparticles inhibit VEGF-and IL-1beta-induced vascular permeability via Src dependent pathway in porcine retinal endothelial cells.Loss of pigment epithelium-derived factor: a novel mechanism for the development of endocrine resistance in breast cancer.Advanced glycation end products and diabetic retinopathy.Dialysate vascular endothelial growth factor is an independent determinant of serum albumin levels and predicts future withdrawal from peritoneal dialysis in uremic patients.PEDF in diabetic retinopathy: a protective effect of oxidative stress.Neurovascular protection by targeting early blood-brain barrier disruption with neurotrophic factors after ischemia-reperfusion in rats*.Administration of pigment epithelium-derived factor delivered by adeno-associated virus inhibits blood-retinal barrier breakdown in diabetic rats.Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats.Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy.Increased serum pigment epithelium-derived factor is associated with microvascular complications, vascular stiffness and inflammation in Type 1 diabetes.Scleroderma fibroblasts suppress angiogenesis via TGF-β/caveolin-1 dependent secretion of pigment epithelium-derived factor.
P2860
Q24644856-999AB668-C74F-4F85-8748-0B326D46B5C4Q25256334-0A610308-D1C1-461B-9B1F-BCE6D93B03EEQ26749178-DF57B96E-72B2-4351-A6C7-FB25A9B3725AQ27026916-D05C0DF9-5692-4599-9463-913063F86A48Q28477836-557E8719-F8AB-4E1D-90EF-EDA5F0B1E2FBQ28576755-1535919B-CC29-4DA5-B0BF-8498B489C786Q30431803-A208BE86-711B-4B4B-9850-438EB8D74EF1Q30465922-46BD0DFC-CA61-4FF2-8887-FF6C6CE11C68Q30483012-2DA36A3D-BEAC-4945-8F28-27656D2CA2DCQ33235324-2ED7C59F-C15D-4ED7-88E5-861204F2AAD1Q33237201-B7114079-33B0-43A1-B4E7-98ACD9B6E27BQ33806214-53A6D10A-5944-41FC-9542-F5EFBD16943AQ33815623-B44CC687-0441-41AE-9256-0F163545B39AQ33938310-6DB6A2DF-818B-4264-AC28-3254A228A57EQ33939170-093D1919-17AA-4D84-AFBD-BC226C309D67Q34058474-1A6B3D97-7E74-4F5A-9A61-EF6B9AF3D6B9Q34275479-6BD7831B-7B54-442D-82E6-CC28980FD057Q34616286-60C9B473-60D3-4FA9-BF3F-30515EF1C1CFQ35034418-34E5B153-8BEF-4053-A8B9-6F780C491281Q35227249-B62C237A-CCC7-49F3-B996-8982A131FD56Q35658364-8D41A966-DAA3-49A2-AD9F-44624FCD1A56Q35710293-308A5BDF-B415-4847-BAEB-60F5CCB74C28Q35906962-FB1ECFF6-F213-44A4-AC50-46B0A1FDCAC2Q36788555-BAAA49F8-FFDF-4433-A85D-3605320AF9CEQ36904857-34B96E63-4696-4C54-A481-0994D9660E64Q37097534-071F04F6-2B13-4985-A117-A546A920C5E6Q37142636-FD88B48B-A1DF-45F5-B2C7-0C3C9CD09107Q37188138-73855306-783B-4F58-A9EA-F90FE761A216Q37238522-1818FB23-6366-48EC-A00F-BE49A28A2450Q37418304-88F97AFA-840B-4BF4-B5F2-FAC8322F7256Q37531200-38D7BC77-EAAC-4BF5-9902-3C520FEB20D4Q37930514-39020964-1282-426F-9805-676121263486Q39312111-AA24B126-D493-4AFE-9E16-08D5033530E3Q39619714-0AB83C61-74A6-481A-A485-52A0EC63CF0AQ39643923-7E91CD05-DCFA-4844-B93B-E1A7971B2CE5Q41370150-54056B91-EFA6-407C-8F70-00C24A233AAEQ46222879-D7708A6D-13E3-4A51-83B7-E68036A4E6D2Q46717201-53B2398F-0D05-49D4-A0A0-8236F82B8CE1Q46923322-4B726987-FBE7-47DE-A1D7-139CE094AB8DQ47280656-DE101259-73BF-4451-AD13-3E17B226D4AB
P2860
Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site.
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Identification of the antivaso ...... ed factor and its active site.
@ast
Identification of the antivaso ...... ed factor and its active site.
@en
type
label
Identification of the antivaso ...... ed factor and its active site.
@ast
Identification of the antivaso ...... ed factor and its active site.
@en
prefLabel
Identification of the antivaso ...... ed factor and its active site.
@ast
Identification of the antivaso ...... ed factor and its active site.
@en
P2093
P2860
P356
P1476
Identification of the antivaso ...... ed factor and its active site.
@en
P2093
Charles E Hawkins
Jian-Guo Ren
Mitra R Cowan
Patrick Y Tong
William L Cooper
P2860
P304
P356
10.1073/PNAS.0308342101
P407
P577
2004-04-19T00:00:00Z